Spain· ES:00150004IP1
ACTOS 30 MG COMPRIMIDOS
A medicinal product containing pioglitazona, registered in Spain by Cheplapharm Arzneimittel Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- pioglitazona
- Manufacturer
- Cheplapharm Arzneimittel Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo76910128EUR 30.07
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pioglitazona in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACTOSCHEPLAPHARM Arzneimittel GmbH, Greifswald
- United KingdomActos 30mg tabletsCST Pharma Ltd
- United StatesActosTakeda Pharmaceuticals America, Inc.
- FinlandActosParanova Oy
- NetherlandsActos 30 mg tablet, tablettenCHEPLAPHARM Arzneimittel GmbH
- SwedenActos 30 mg TablettCheplapharm Arzneimittel GmbH
- ItalyACTOSCHEPLAPHARM ARZNEIMITTEL GMBH
- CanadaACH-PIOGLITAZONEACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Bulgaria · Pioglitazone Sanovel, Пизона
- Cyprus · Zipion
- Czechia · Novapio, Pioglitazon Viatris
- Germany · Pioglitazon Aurobindo
- United Kingdom (Northern Ireland) · Pioglitazone Brown And Burk Uk Ltd, Pioglitazone Generics
- Greece · Glitact, Raglitan
- Croatia · Novapio, Pioglitazon Pliva
- Iceland · Actos, Pioglitazone Accord
- Italy · Pioglitazone Aurobindo, Pioglitazone Doc Generici
- Liechtenstein · Actos, Pioglitazone Accord
- Latvia · Zipion
- Malta · Novapio
- Netherlands · Pioglitazone Hydrochloride Aurobindo, Pioglitazone Sanovel
- Norway · Actos, Pioglitazone Accord
- Poland · Pioglitazone Bioton
- Portugal · Pioglitazona Atrolex, Pioglitazona Aurovitas
- Sweden · Pioglitazone Holsten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecc8ee18-885c-4833-852a-69b2b4d73b26 GET /v1/drugs/ecc8ee18-885c-4833-852a-69b2b4d73b26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1762525800000}",
"nregistro": "00150004IP1",
"substance": "pioglitazona"
}See everything about pioglitazona.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.